Yahoo Finance

Laborie's Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan

PORTSMOUTH, N.H., July 10, 2025 /PRNewswire/ -- Effective July 1, 2025, Blue Cross Blue Shield of Michigan (BCBSM) has issued a new medical policy under CPT code 52284, extending coverage for Laborie ...
Yahoo Finance

Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology

PORTSMOUTH, N.H., Jan. 17, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its ...
PR Newswire

FDA Approves Optilume® Urethral Drug Coated Balloon, a breakthrough treatment for urethral strictures

MINNEAPOLIS, Dec. 13, 2021 /PRNewswire/ -- Urotronic, Inc., a Minnesota based medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Optilume® ...
Medindia

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

PORTSMOUTH, N.H., April 30, 2024 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leading diagnostic and therapeutic medical technology company, welcomed the inclusion of Optilume ® ...
Mena FN

Optilume Drug-Coated Balloon Shows Long-Term Efficacy For Urethral Strictures: Five-Year Data Published In The Journal Of Urology

Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its Optilume® Drug-Coated Balloon (DCB). The ...